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Abstract
Background: The purpose of this study was to compare risk predicted using available risk
scores and actual outcomes in patients with left main coronary artery disease undergoing
percutaneous coronary intervention with stent implantation (PCI LM).
Methods: We studied 204 patients treated with elective or emergent coronary angioplasty. We
estimated in-hospital mortality using the EuroSCORE, Parsonnet and GRACE risk scores
and compared this data with actual in-hospital mortality.
Results: There were no deaths among 62 patients undergoing elective PCI LM regardless of
the estimated risk. Acute coronary syndrome (ACS) was diagnosed in all 142 patients under-
going emergent PCI LM. Mortality in this group was 24% (34/142). Area under receiver
operating characteristic curve (AUC) values for the EuroSCORE, Parsonnet and GRACE risk
scores in patients with ACS were 0.812 (p = 0.0001), 0.857 (p = 0.0001), and 0.870 (p = 0.0001),
respectively. No statistically significant differences were found when these AUC values for
different evaluated risk scores were compared. Overall, the EuroSCORE and Parsonnet risk
scores had no discriminative value, as all deaths occurred in the highest risk group. Only the
GRACE risk score discriminated risk among intermediate- and high-risk patients with ACS.
Conlusions: The EuroSCORE and Parsonnet scoring systems are of no value in predicting
periprocedural mortality risk in patients undergoing elective PCI LM. Overall, discriminative
ability of the EuroSCORE, Parsonnet, and GRACE risk scores in unselected patients with
ACS undergoing emergent PCI LM was good. In this group of patients, the EuroSCORE and
Parsonnet scoring systems had no discriminative value in low and moderate risk patients.
Only the GRACE risk score discriminated risk among intermediate and high risk patients.
(Cardiol J 2008; 15: 268–276)
Key words: left main coronary artery disease, percutaneous coronary angioplasty,
EuroSCORE, Parsonnet risk score, GRACE risk score
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Introduction
Left main coronary artery disease (LM CAD),
present in 5–9% of patients with angina pectoris, is
associated with particularly unfavorable prognosis
when treated medically, because 1- and 3-year
mortality of 19% and 50%, respectively, has been
reported in such patients [1, 2]. Coronary Artery
Study (CASS) showed large advantage of coronary
artery bypass grafting (CABG) over medical treat-
ment in patients with LM CAD, as 5-year survival
following CABG was 84% compared to 58% among
patients treated medically [3]. Thus, revasculariza-
tion is the method of choice when significant LM
CAD is detected. In American College of Cardiolo-
gy/American Heart Association guidelines, CABG
is the treatment of choice for unprotected left main
coronary artery stenosis (Class I recommendation,
level of evidence A) [4].
The first percutaneous coronary intervention
(PCI) in a patient with unprotected left main corona-
ry artery stenosis was performed by Andreas Gru-
entzig in 1978 [5]. However, despite good imme-
diate results this treatment was soon abandoned in
favor of CABG due to unfavorable long-term outco-
mes [6]. During later years, hemodynamically signi-
ficant left main coronary artery stenosis, particular-
ly when unprotected by at least one patent coronary
bypass graft, was considered an absolute contrain-
dication for percutaneous revascularization [2, 3].
However, dynamic growth of invasive cardio-
logy, widespread use of stents, including antimito-
tic drug-eluting stents, and introduction of new an-
tiplatelet agents created new therapeutic possibili-
ties also in the treatment of LM CAD. Despite these
advances, current guidelines state that PCI of left
main coronary artery stenosis should only be per-
formed (Class IIa recommendation, level of eviden-
ce B) if surgical revascularization is not possible or
the operative risk is prohibitively high (e.g. > 10
points using the EuroSCORE scoring system) [7, 8].
Risk prediction in cardiac surgery is based on
several commonly used risk scores, such as the
Parsonnet risk score [9, 10] and the EuroSCORE
scoring system [11–14]. Risk prediction in patients
with acute coronary syndromes is currently based
on the Global Registry of Acute Coronary Events
(GRACE) risk score [15,16]. These risk scores
were validated in large patient populations. Howe-
ver, LM CAD is a unique clinical condition and the
predictive value of these risk scores in such patients
is not necessarily as good as in more general popu-
lation of cardiac patients. Currently, only few data
are available regarding the use of these risk scores
in LM CAD, as their predictive value was not com-
prehensively evaluated in such patients and existing
studies were performed in relatively small groups.
Purpose of the study
The purpose of this study was to compare peri-
procedural mortality risk predicted using available
risk scores and actual outcomes in our patients with
LM CAD undergoing PCI with stent implantation.
Methods
From August 2001 do January 2006, coronary
angioplasty with stenting of the left main coronary
artery was performed in 204 patients treated in the
Department of Cardiology and Internal Medicine at
the University Hospital in Bydgoszcz, Poland. The-
se procedures amounted to 2.8% of all PCI proce-
dures performed during the study period. All inte-
rventions were performed according to standard
PCI procedures. Prior to PCI, patients were given
1 mg/kg of heparin (or 0.7 mg/kg if abciximab was
concurrently used), acetylsalicylic acid and ticlopi-
dine or clopidogrel. Following the procedure, all
patients were treated with acetylsalicylic acid and
ticlopidine or clopidogrel. PCI was preceded by co-
ronary angiography. Bare metal stents or, in
15 patients, drug-eluting stents (DES) were implan-
ted into the left main coronary artery at the discretion
of the physician performing the procedure. In addition,
72 patients were treated with abciximab infusion.
All patients gave informed consent for corona-
ry angioplasty. The study protocol was revised and
approved by a local Ethics Committee. The study
group characteristcs is presented in Table 1.
Table 1. Clinical characteristics of the study
population.
Diabetes 77 (37.7%)
Hypertension 140 (68.6%)
Hypercholesterolemia 153 (75%)
Cigarette smoking 113 (55.4%)
Creatinine level ≥ 2 mg/dL 11 (5.4%)
Previous stroke 29 (14.2%)
UA/NSTEMI as the indication for PCI 58 (28.4%)
STEMI as the indication for PCI 84 (41.2%)
Resuscitated cardiac arrest 22 (10.8%)
Cardiogenic shock on admission 65 (31.9%)
Intra-aortic balloon pump necessary 22 (10.8%)
during treatment
PCI — percutaneous coronary intervention; NSTEMI — non-ST segment
elevation myocardial infarction; STEMI — ST segment elevation
myocardial infarction; UA — unstable angina
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We studied 204 patients (mean age 65.5 years,
range 26–85 years), including 55 women (mean age
70 years, range 44–85 years) and 149 men (mean
age 63 years, range 26–83 years). The study group
was divided into two subgroups of 62 patients (30%)
undergoing elective treatment and 142 patients
(70%) undergoing emergent treatment.
Among patients undergoing elective coronary
angioplasty, left main coronary artery was protected
by at least one patent coronary bypass graft in 8 pa-
tients, 6 patients were deemed not suitable for CABG,
and 46 patients did not give consent for CABG.
Acute coronary syndrome (ACS) was diagno-
sed in patients undergoing emergent coronary an-
gioplasty, including 58 patients (41%) with non-ST
segment elevation ACS and 84 patients (59%) with
ST segment elevation ACS. On admission, 65 pa-
tients (46%) were in cardiogenic shock, and 20 pa-
tients (14.1%) have been resuscitated following
a cardiac arrest. Left main coronary artery was pro-
tected by at least one patent coronary bypass graft
in 16 patients. Intra-aortic balloon pump was used
in 22 patients (15.5%). In five cases, the immedia-
te cause of stent implantation was iatrogenic dis-
section of the left main coronary artery during ca-
theterization and angiography.
The most obvious alternative treatment in such
patients is cardiac surgery. Therefore, we evaluated
cardiac surgery risk using a European scoring sys-
tem known as the EuroSCORE. According to this
system, patients assigned 0–2 points are conside-
red a low surgical risk group with estimated perio-
perative mortality of 0.8%, patients assigned 3–
–5 points are considered an intermediate surgical
risk group with estimated perioperative mortality
of 3%, and patients assigned 6 or more points are
considered a high surgical risk group with estima-
ted perioperative mortality exceeding 11.2%. Ano-
ther risk score allowing rapid, bedside estimation
of the perioperative risk is the Parsonnet score. In
this scoring system, 0–4, 5–9, 10–15, 15–19, and
20+ points correspond to the estimated mortality
of 1%, 5%, 9%, 17%, and 31%, respectively. In all
patients with ACS, we also evaluated in-hospital
mortality risk using the GRACE risk score.
Statistical analysis
All calculations and analyses were performed
using Statistica package, version 7.1 PL (StatSoft,
Tulsa, USA), and MedCalc for Windows, version
9.2.0.0 (MedCalc Software, Mariakerke, Belgium).
P<0.05 was considered statistically significant.
Normal distribution of variables was tested using
Kolmogorov-Smirnov and Shapiro-Wilk tests.
For variables with skewed distribution, data were
presented as median values and ranges. Receiver
operating characteristic (ROC) curves were used
for statistical analysis [17, 18]. Area under ROC
curve (AUC) was calculated to determine discrimi-
native value of a given score. AUC values were
compared using Hanley and McNeil method [19].
Results
Among 62 patients undergoing elective PCI
with stent implantation, the EuroSCORE scoring
system indicated low operative risk in 23 (37.1%)
patients, intermediate risk in 23 (37.1%) patients,
and high risk in 16 (25.8%) patients. According to
the Parsonnet score, perioperative mortality risk
was 1% in 4 (6.5%) patients, 5% in 14 (22.6%) pa-
tients, 9% in 16 (25.8%) patients, 17% in 13 (21%)
patients, and 31% in 15 (24,2%) patients. However,
there were no deaths in this patient group regar-
dless of the estimated risk.
Among 142 patients with ACS undergoing
emergent PCI with stent implantation, 34 deaths
(24%) occurred, including 7 deaths (12.1%) among
58 patients with unstable angina/non-ST segment
elevation myocardial infarction (UA/NSTEMI), and
27 deaths (32.1%) among 84 patients with ST seg-
ment elevation myocardial infarction (STEMI).
Among patients with UA/NSTEMI, 14 patients
were in cardiogenic shock and half of them died.
Among patients with STEMI, 51 patients were in
cardiogenic shock and 25 of them (49%) died. Ove-
rall, death ensued in 32 (49.2%) of 65 patients
(45.8% of all patients with ACS) who were in car-
diogenic shock prior to PCI.
Evaluation using the EuroSCORE scoring sys-
tem indicated low operative risk in 4 (2.8%) patients
with ACS, intermediate risk in 14 (9.9%) patients,
and high risk in 124 (87.3%) patients. All 34 patients
who died (24%) belonged to the latter group (Fig. 1).
According to the Parsonnet score, perioperative
mortality risk was 1% in 4 patients, 5% in 2 patients,
9% in 13 patients, 17% in 18 patients, and 31% in
105 (73.9%) patients. Again, all 34 patients who died
(32.4%) belonged to the highest risk group (Fig. 2).
Among 142 patients with ACS, in-hospital mor-
tality risk estimates based on the GRACE risk sco-
re were as follows: estimated risk was less than 1%
in 7 (4.9%) patients and 1–4% in 30 (21.1%) pa-
tients, with no deaths in these two groups; while
one patient (4%) died out of 25 (17.6%) patients with
the estimated mortality risk of 5–8%, 4 patients
(21.1%) died out of 19 (13.4%) patients with the
estimated mortality risk of 9–19%, and 29 patients
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(47.5%) died out of 61 (43%) patients with the esti-
mated mortality risk of ≥ 20% (Fig. 3).
Overall, AUC was 0.876 (p = 0.0001) for the
EuroSCORE scoring system and 0.870 (p = 0.0001)
for the Parsonnet risk score. No statistically signi-
ficant difference was found when these AUC valu-
es were compared (p = 0.860) (Fig. 4, Table 2).
In patients with ACS, AUC values for the Eu-
roSCORE, Parsonnet and GRACE risk scores were
0.812 (p = 0.0001), 0.805 (p = 0.0001), and 0.857
(p = 0.0001), respectively. No statistically signifi-
Figure 1. Predicted operative risk by the additive Euro-
SCORE scoring system and the actual risk in patients
undergoing emergent percutaneous coronary intervention
of the left main coronary artery stenosis (pt — points).
Figure 3. Predicted mortality risk by the GRACE scoring
system and the actual risk in patients undergoing emer-
gent percutaneous coronary intervention of the left
main coronary artery stenosis.
cant differences were found when these AUC valu-
es were compared pair-wise (Fig. 5, Table 3).
Discussion
In the current era of widespread use of coro-
nary stents, including antiproliferative DES, and
antiplatelet drugs such as clopidogrel and ticlopidi-
ne, it is debatable whether left main coronary arte-
ry stenosis should still be considered an absolute
contraindication to PCI [20]. This debate regarding
the optimal treatment of the left main coronary ar-
tery stenosis has been fueled by the results of mul-
ticenter French Left Main study (FLM) and the
recent results of the LE MANS study, showing lo-
wer one-year mortality in patients treated with co-
ronary angioplasty and stenting compared to CABG
[21, 22].
Previous studies suggest that the early and
long-term results of PCI in patients with LM CAD
depend on the baseline clinical status [23]. Risk fac-
tors for mortality among patients undergoing angio-
plasty of the left main coronary artery stenosis in-
clude low left ventricular ejection fraction (LVEF),
significant mitral regurgitation, cardiogenic shock,
acute myocardial infarction, renal failure, multives-
sel coronary artery disease and postprocedural
stent lumen diameter [1, 24–26]. Recently, an in-
creased preprocedural high-sensivity C-reactive
protein (hsCRP) level has also been shown to be
a risk factor for adverse outcomes [27].
Our data show no major complications and
deaths during in-hospital follow-up of patients
Figure 2. Predicted mortality risk by the Parsonnet sco-
ring system and the actual risk in patients undergoing
emergent percutaneous coronary intervention of the
left main coronary artery stenosis (pt — points).
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undergoing elective PCI of LM CAD. Notably, some
of these patients were previously refused CABG
due to perceived high surgical risk, and some pa-
tients did not give consent for CABG. In the study
by Brener et al. [28] in 97 patients with LM CAD
treated with stent implantation, risk factors for ad-
verse outcomes were the number of points by the
EuroSCORE scoring system and diabetes. In the
Table 2. Area under ROC curve (AUC) values for the EuroSCORE and Parsonnet risk scores and their
comparison in the overall study population.
AUC Standard error 95% confidence interval p
Risk estimation model
EuroSCORE 0.876 0.0396 0.823 to 0.918 0.0001
Parsonnet 0.870 0.0404 0.816 to 0.913 0.0001
Comparison of models DAUC
EuroSCORE vs. Parsonnet 0.00588 0.0333 –0,0594 to 0.0712 0.860
DAUC — difference between AUC values for the two risk scores
Figure 5. ROC curves for the EuroSCORE, GRACE and
Parsonnet risk scores in patients with acute coronary
syndromes.
Figure 4. ROC curves for the EuroSCORE and Parsonnet
risk scores in the overall study population.
Table 3. Area under ROC curve (AUC) values for the EuroSCORE, GRACE and Parsonnet risk scores
and their comparison in patients with acute coronary syndromes.
AUC Standard error 95% confidence interval p
Risk estimation model
EuroSCORE 0.812 0.0475 0.738 to 0.872 0.0001
GRACE 0.857 0.0427 0.788 to 0.910 0.0001
Parsonnet 0.805 0.0481 0.730 to 0.867 0.0001
Comparison of models DAUC
EuroSCORE vs. GRACE 0.0451 0.0349 –0.234 to 0.114 0.197
EuroSCORE vs. Parsonnet 0.00681 0.0388 –0.0692 to 0.0828 0.861
GRACE vs. Parsonnet 0.0519 0.0366 –0.0199 to 0.124 0.157
DAUC — difference between AUC values for risk scores compared pairwise
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study by Silvestri et al. [29] who evaluated 140 patients
who underwent elective PCI of the left main coro-
nary artery stenosis (excluding patients with acute
myocardial infarction and/or cardiogenic shock),
30-day mortality was 0% in the low operative risk
group and 9% in the high operative risk group. The
latter included patients with contraindications to
CABG and patients with at least one of the follo-
wing risk factors: advanced age (> 75 years), pre-
vious cardiac surgery, LVEF < 35%, renal failure,
severe respiratory failure, and poor distal coronary
outflow [29]. In our study, no in-hospital deaths
were noted among patients who underwent electi-
ve angioplasty of the left main coronary artery even
in high surgical risk groups by the EuroSCORE and
Parsonnet risk score criteria. These results are
comparable to those reported by Kim et al. [30],
with no periprocedural deaths in a group of 324 pa-
tients who underwent elective angioplasty of the left
main coronary artery. Patients with acute STEMI
and patients undergoing urgent angioplasty within
24 hours from the onset of symptoms were exclu-
ded from that study. In contrast to studies by
Silvestri et al. [29] and by Kim et al. [30], we analy-
zed all patients undergoing angioplasty of the left
main coronary artery, including patients with acu-
te STEMI (41.2% of all patients) and patients with
cardiogenic shock (31.9% of patients). In a study in-
volving 104 patients, Christiansen et al. [31] sho-
wed that 30-day mortality in low and high operati-
ve risk groups and in patients with acute myocar-
dial infarction was 0%, 16% and 37%, respectively,
and predicted mortality using the EuroSCORE sco-
ring system was 2%, 8% and 18%, respectively.
Among our patients undergoing emergent PCI of
the left main coronary artery, mortality in low, in-
termediate and high operative risk groups was 0%,
0% and 24%, respectively, while predicted morta-
lity using the EuroSCORE scoring system was
0.8%, 3% and 11.2%, respectively. Multicenter
ULTIMA registry, involving the largest patient
population so far (n = 279), showed that the outco-
mes following angioplasty of an unprotected left
main coronary artery stenosis in patients with low
operative risk were better (no periprocedural de-
aths, one-year mortality of 3.4%) than the results
of CABG in similar patients. One-year mortality
among patients with intermediate operative risk
was 24.4%, and it exceeded 56% among patients
with high operative risk [1]. Among patients with
acute myocardial infarction treated with angiopla-
sty and stenting of the left main coronary artery,
periprocedural mortality was 35%, and one-year
mortality was 55% [32]. Outcomes of stenting were
worse in patients with impaired left ventricular
function (LVEF < 30%), significant mitral regurgi-
tations, renal disease, and advanced age (> 75
years) [25, 33, 34]. However, these were high ope-
rative risk patients who were often denied surgical
treatment. In contrast to the above results, in-ho-
spital mortality was only 1.7% and one-year morta-
lity was 5.1% among 297 patients treated with PCI
of the left main coronary artery, reported by Han
et al. [35] in a single-center Chinese study. This
group included 23.9% patients undergoing emer-
gent PCI, 45.1% patients with unstable angina, 7.1%
patients with acute myocardial infarction and 4%
patients in cardiogenic shock.
LM CAD is a rare cause of an acute myocar-
dial infarction (0.37–0.6%) [36, 37]. However, pro-
gnosis is very poor in patients with a left main co-
ronary artery stenosis that led to an acute myocar-
dial infarction complicated by a cardiogenic shock
(so called left main shock syndrome), with peripro-
cedural mortality of 32–94% [25, 32, 33, 38–41].
Few studies have been published that reported re-
sults of surgical revascularization in such patients.
Nakanishi et al. reported mortality of 46% among
patients undergoing CABG due to an acute myocar-
dial infarction (n = 13), including 53% patients in
cardiogenic shock [42]. Despite indications for
CABG, significant logistic problems (time required
for preparation to operation, patient transport to the
operating room) commonly make the performance
of the surgical procedure impossible. Thus, it se-
ems that immediate PCI with stenting might often
be the only practical effective treatment. Despite
lack of large studies, mounting evidence from smal-
ler groups of patients show effectiveness of such
strategy, with mortality reduced to 32–44% [32, 39–
–41, 43].
Risk prediction models, such as the EuroSCORE
and Parsonnet risk scores, are commonly used in
cardiac surgery to predict operative risk [9–14].
Usefulness of the EuroSCORE scoring system was
also shown for predicting PCI-related risk for high
risk procedures [44–46]. Despite independent re-
lation between the number of points and the risk of
death, these scores have limited usefulness in pre-
dicting PCI-related risk. As these models were de-
rived from data on the outcomes of surgical treat-
ment, some parameters might bear no relation to
PCI-related risk. This limitation may explain lack
of relation between the number of points by these
scoring systems and PCI outcomes in patients under-
going elective treatment that was observed in our
study. In this population, no deaths were noted du-
ring short-term follow-up among patients undergoing
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elective PCI, although about 25% of patients could
be categorized as highest risk. This might be expla-
ined by a low number of patients in our study, but
it might also result from limited usefulness of such
scoring systems in patients undergoing PCI due to
associated low mortality.
We found good discriminative ability of the
EuroSCORE and Parsonnet risk scores in patients
undergoing emergent PCI, as evaluated using AUC
values for respective ROC curves (0.812 and 0.805,
respectively). However, mortality risk analysis
using these scoring systems showed poor discriminati-
ve value among low and moderate risk patients, as all
deaths occurred in the highest risk group (Fig. 1, 2).
These discrepant findings may be explained by
a large number of patients in cardiogenic shock
(45.8%), mostly related to STEMI. This population
is characterized by high mortality exceeding 50%
[25, 32, 47, 48].
Discriminative value of the GRACE risk score
in the same group of patients tended to be highest
(AUC = 0.857), although we found no significant
difference compared to the other risk scores. This
model also had no discriminative value among low
risk patients (estimated mortality risk 1–4%) but
tended to have better discriminative value among
moderate risk patients (estimated mortality risk 5–
–19%) and high risk patients (estimated mortality
risk ≥ 20%) (Fig. 3). These findings suggest an ad-
vantage of the GRACE risk score over the other
evaluated risk prediction models in regard to the
estimation of PCI-related risk in patients with ACS
undergoing PCI of the left main coronary artery.
Study limitations
We studied unselected patients with LM CAD,
including 24 (11.8%) patients with protected left
main coronary artery stenosis. Most patients un-
derwent emergent angioplasty and stenting of the
left main coronary artery, including 46% patients
in cardiogenic shock and 14.1% patients who had
been resuscitated following a cardiac arrest. Due to
all these factors, precise determination of the ba-
seline clinical status as related to risk estimation
using the EuroSCORE and Parsonnet scoring sys-
tems (no baseline echocardiographic evaluation,
incomplete history regarding risk factors) was dif-
ficult and resulted in underestimation of predicted
risk in critically ill patients. The EuroSCORE sco-
ring system may underestimate risk in higher risk
patients. Due to relatively low number of patients,
multivariate analysis of the differences between
predicted and actual risk could not be reliably per-
formed.
Conclusions
The EuroSCORE and Parsonnet scoring sys-
tems are of no value in predicting periprocedural
mortality risk in patients undergoing elective left
main coronary artery stenting. Overall, discrimina-
tive ability of the EuroSCORE, Parsonnet, and
GRACE risk scores in unselected patients with ACS
undergoing emergent PCI of LM CAD was good.
In this group of patients, the EuroSCORE and Par-
sonnet scoring systems had no discriminative va-
lue in low and moderate risk patients, as all deaths
occurred in the highest risk group. Only the
GRACE risk score discriminated risk among inter-
mediate and high-risk patients with acute coronary
syndrome.
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